News of Note—Teva accused of shortcutting plant sale; Sun plant gets only one observation

newspapers
(Pixabay)

> Teva has been sued by an Israeli businessman who claims his bid for the land use for two plants the drugmaker is closing in Jerusalem was overlooked. Story

> Sun Pharmaceutical has received on observation during a January FDA inspection of its plant in Halol. Form 483 (PDF)

> Strides says the FDA has approved a new dosage plant in Singapore. Filing (PDF)

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

> Shanghai-based WuXi STA has received EMA approval for a new drug product manufacturing facility in the Waigaoqiao Free Trade Zone of Shanghai. Release

> Lupin has received EU approval for a biologics plant in India. Story

> Cambrex says it has doubled the liquid filling capacity at its plant in Mirabel, Québec. Release